Endothelial cells: A novel key player in immunoregulation in acute graft-versus-host disease?

被引:6
作者
Zhou, Hao [1 ]
Li, Quan [1 ]
Zou, Ping [1 ]
You, Yong [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430022, Peoples R China
基金
中国国家自然科学基金;
关键词
T-CELLS; GALECTIN-9; AUTOIMMUNE; EXPRESSION;
D O I
10.1016/j.mehy.2008.12.028
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Graft-versus-host disease (GVHD) is a lethal complication of allogeneic hematopoietic stem cell transplantation where activated donor T cells attack the genetically disparate host cells. The main target organs of the T cells in GVHD are the skin, liver, and intestine. in order to explain why the lung, one of the barrier organs, is spared from the injury of effector T cells, we hypothesize that endothelial cells are essential for immune regulation in acute GVHD. The proposed mechanism including Th1 cells apoptosis induced by endothelial cells expressing Tim-3 ligand galectin-9, and differential expression levels of galectin-9 on endothelial cells in various organs. The elucidation of the detailed cellular and molecular mechanisms that involved may help to a better understanding of immunoregulation in acute GVHD. Furthermore, the hypothesis may offer improved insight into new therapeutic strategy to reduce the severity of GVHD. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:567 / 569
页数:3
相关论文
共 16 条
[1]   Prophylaxis of acute GVHD: manipulate the graft or the environment? [J].
Barrett, A. John ;
Le Blanc, Katarina .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) :165-176
[2]   Vascular endothelium and graft-versus-host disease [J].
Biedermann, Barbara C. .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) :129-138
[3]   In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens [J].
Dickinson, AM ;
Wang, XN ;
Sviland, L ;
Vyth-Dreese, FA ;
Jackson, GH ;
Schumacher, TNM ;
Haanen, JBAG ;
Mutis, T ;
Goulmy, E .
NATURE MEDICINE, 2002, 8 (04) :410-414
[4]   The pathophysiology of acute graft-versus-host disease [J].
Ferrara, JLM ;
Cooke, KR ;
Teshima, T .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (03) :181-187
[5]   Acute graft-vs-host disease: Pathobiology and management [J].
Goker, H ;
Haznedaroglu, IC ;
Chao, NJ .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (03) :259-277
[6]   The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement? [J].
Har-Noy, M. ;
Slavin, S. .
MEDICAL HYPOTHESES, 2008, 70 (06) :1186-1192
[7]   A New Approach to the Blocking of Alloreactive T Cell-Mediated Graft-versus-Host Disease by In Vivo Administration of Anti-CXCR3 Neutralizing Antibody [J].
He, Shan ;
Cao, Qi ;
Qiu, Yuhua ;
Mi, Jianqing ;
Zhang, Jingwu Z. ;
Jin, Min ;
Ge, Hailiang ;
Emerson, Stephen G. ;
Zhang, Yi ;
Zhang, Yanyun .
JOURNAL OF IMMUNOLOGY, 2008, 181 (11) :7581-7592
[8]   15-Deoxy-Δ12,14-prostaglandin J2 inhibits IFN-γ-induced galectin-9 expression in cultured human umbilical vein endothelial cells [J].
Imaizumi, T ;
Kumagai, M ;
Nishi, N ;
Hirashima, M ;
Hatakeyama, M ;
Tamo, W ;
Yoshida, H ;
Nakamura, T ;
Okumura, K ;
Satoh, K .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2003, 131 (01) :57-61
[9]  
Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486
[10]  
Imamura Masahiro, 2003, Hematology, V8, P19, DOI 10.1080/1024533031000072045